Location
United States, North America
Check Size
$10K - $100M
Investment Stage
Series A
Series B
Focus Areas
Health IT
BioTech
About Investor
Vineeta Agarwala is a General Partner at Andreessen Horowitz in San Francisco, writing $10 K–$100 M checks from seed through Series B into biotech and health-IT startups. A practicing physician and former clinical instructor at Stanford, she previously served as a venture partner at GV and led product strategy at Roche’s digital health group, blending medical expertise with tech commercialization.
Previous investments
Gate Bioscience
60M |2023
Arda Therapeutics
43M |2024
Thyme Care
55M |2024
60M |2023
22M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,NS
Nikhil Shah
United States, North America
$5K - $50K
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP